Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 160 matches for

San Diego based Abide Therapeutics is collaborating with the University of Oxford and the Oxford University Hospitals NHS Trust to explore the therapeutic potential of serine hydrolases, a validated but under-explored class of drug targets.

New Associate Professors

Three new Associate Professor were awarded the title in the most recent Recognition of Distinction round.

A multidisciplinary team of scientists aims to solve the mystery of magnetoreception

Experts are investigating whether invisible magnetic forces which guide migrating animals around the globe can also affect humans.

Professor Robert MacLaren in the top 100 ophthalmologists worldwide

In 2024 Professor Robert MacLaren was ranked in the top 100 ophthalmologists worldwide by the international Ophthalmologist magazine.

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

Wellcome Discovery Award granted to Professor Robert MacLaren

Professor Robert MacLaren has been awarded a prestigious Wellcome Discovery Award to advance the development of CRISPR strategies to treat inherited retinal diseases, which are a leading cause of childhood visual impairment in the UK and of blindness in people of working age.

Professor Russell Foster awarded Foreign Fellowship of INSA

Congratulations to Professor Russell Foster, Head of the Nuffield Laboratory of Ophthalmology and Director of the Sir Jules Thorn Sleep and Circadian Neuroscience Institute, on his election as a Foreign Fellow of the lndian National Science Academy.

Russell Foster featured in 100 Faces campaign

The campaign which launched on the 15th April 2024 celebrates the stories and achievements of students who were the first in their family to go to university.

Brief sleep therapy delivered by nurses improves insomnia

Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.

New imaging method trialled for retinal diseases

Clinical scientists in Oxford have presented a new method of imaging of the retina that overcomes many of the drawbacks of the current standard way of diagnosing and monitoring retinal diseases like age-related macular degeneration (AMD).

Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases

Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.

Colin Espie becomes a Fellow of the Academy of Medical Sciences

Professor Espie is one of eight Oxford researchers to become Fellows of the Academy of Medical Sciences.

Ophthalmology Conference in Kyiv

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

Visit from the Sir Jules Thorn Charitable Trust

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Obituary: Carol Holder

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

New genetic diagnosis technology for eye disease receives major funding award

Eye2Gene explores the use of AI to determine which genetic condition is causing a patient’s inherited retinal disease, by examining eye scans.

How our dreams changed during the COVID-19 pandemic

This study explored associations between COVID-19 and dream recall frequency, and related social, health, and mental health factors.

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Load More

Similar stories